Brexit Pharmaceutical Trade Implications

The UK’s departure from the European Union, also known as Brexit, has added significant trade complications between the UK and the EU. View our webinar to learn more about the arrangements necessary for the trade in medicines between the UK and the EU which have applied since the beginning of 2021.

This webinar is presented by Pete Gough. He has over 45 years’ experience in the pharmaceutical industry and for nearly 20 years has been responsible for advising senior management on changes to pharmaceutical legislation and guidance. He is an NSF subject matter expert and runs a multitude of pharmaceutical regulatory courses.